Thermo Fisher Scientific Inc., US8835561023

Thermo Fisher Scientific stock approaches Q3 results after 10.5 percent growth

Published on 10/07/2026 at 15:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Thermo Fisher Scientific stock traded at USD 655.33 on October 7, 2026, while Q2 adjusted EPS beat consensus by USD 0.32. Q3 results are set for October 21.

Aquarellbild eines gläsernen Forschungscampus an einem Fluss mit herbstlichen Bäumen — Aquarellmalerei symbolisiert Thermo Fisher Sci. US8835561023 mit gläsernem Forschungscampus entlang eines ruhigen Flusses im Herbst, Illustration mit AI erstellt.

Thermo Fisher Scientific stock (ISIN US8835561023) was trading at USD 655.33 on the NYSE on October 7, 2026, down 0.19 percent from the prior close of USD 656.58. The company has scheduled its third-quarter 2026 results and earnings call for October 21, 2026, at 7:00 a.m. ET, according to Thermo Fisher Scientific.

Q2 growth sets the benchmark

MarketBeat reported that Thermo Fisher delivered adjusted EPS of USD 6.03 in Q2 2026, exceeding the USD 5.71 consensus by USD 0.32. Revenue reached USD 11.99 billion, up 10.5 percent from the same quarter a year earlier and above the USD 11.71 billion consensus.

The result gives the October 21 reporting date a clear benchmark. Adjusted EPS must now be measured against the Q2 level, while revenue growth must show whether demand across research, diagnostics and biopharma services remains broad.

Four segments drive the comparison

The Q2 mix was also quantified in the company filing summary. According to StockTitan, Laboratory Products and Biopharma Services revenue grew 12 percent, Life Sciences Solutions increased 13 percent, Analytical Instruments rose 7 percent and Specialty Diagnostics advanced 6 percent in Q2 2026.

That spread matters because the growth was not tied to one operating line. It also leaves the next report with several measurable comparison points, including the 13 percent increase in Life Sciences Solutions and the 7 percent gain in Analytical Instruments.

Analysts trail the current quote

MarketBeat lists a Moderate Buy consensus from 26 analysts, comprising two Strong Buy ratings, 18 Buy ratings, four Hold ratings and two Sell ratings. The average price target is USD 628.78, so the price lies 4.1 percent above the consensus target based on the October 7 quote.

The contrast is important for investors reading the upcoming report. Operating growth remains the measurable support, while the consensus target sits below the current market level and makes the next earnings update a test of whether estimates can move higher.

Stock stays below yearly high

Thermo Fisher Scientific stock was trading at USD 655.33 on the NYSE on October 7, 2026, with a market capitalization of USD 242.3 billion and volume of 285,221 shares. The price was 5.6 percent below the 52-week high of USD 694.33 and above the 52-week low of USD 435.27.